本研究旨在探讨前庭康复对平衡的影响,动态视力,双侧前庭功能减退(BVH)患者的生活质量。该研究包括通过视频眼震描记术诊断的20名患者。平衡测试,视觉模拟量表(VAS),动态视觉敏锐度(DVA)测试,头晕障碍库存(DHI),平衡感觉相互作用的计算机修改的临床测试(m-CTSIB),在治疗前和治疗后3个月和6个月进行稳定性极限试验。每隔两周进行一次物理治疗。根据患者的发展情况,他们被要求执行家庭锻炼计划,每天重复10次3次。经过6个月的前庭康复,观察到患者平衡和生活质量参数改善.VAS,DVA,DHI,除了Romberg以外的所有静态平衡参数,半串联睁眼是显著的(p<0.005)。在计算机化的M-CTSIB中,虽然在眼睛睁开的硬表面上没有获得显著的结果(p=0.126),在闭眼的硬表面和睁眼和闭眼的泡沫表面上观察到统计学上的显着改善。LOS结果显示速度显著提高,到达终点,以及除右后方外所有方向的最大偏差。虽然在右边发现了显著的结果,后部,左前,反应时间部分的左后方,任何直接对照切片均无统计学意义(p<0.005).试用注册号:NCT05231109,注册日期:2022年1月27日(回顾性注册)。
This study aims to investigate the effectiveness of vestibular rehabilitation on balance, dynamic visual acuity, and quality of life in patients with bilateral vestibular hypofunction (BVH). 20 patients diagnosed by videonystagmography were included in the study. Balance tests, Visual Analogue Scale (VAS), testing of Dynamic Visual Acuity (DVA), Dizziness Handicap Inventory (DHI), Computer-modified Clinical Test of Sensory Interaction in Balance (m-CTSIB), and Limits of Stability Test were applied before and 3 and 6 months after the treatment. Physiotherapy sessions were given at two-week intervals. According to the development of the patients, they were asked to perform a home exercise program with 10 repetitions 3 times a day. After 6 months of vestibular rehabilitation, improvements in balance and quality of life parameters were observed in the patients. VAS, DVA, DHI, all static balance parameters except Romberg, Semi-tandem eyes open were significant (p < 0.005). In computerized M-CTSIB, while no significant results were obtained on the hard surface with the eyes open (p = 0.126), statistically significant improvement was observed on the hard surface with the eyes closed and on a foam surface with eyes open and close. LOS results showed significant improvement in velocity, reaching the endpoint, and maximal deviation in all directions except the right posterior. While significant results were found in the right, posterior, left anterior, and left posterior directions in the reaction time section, there was no statistical significance in any of the direct control sections (p < 0.005). Trial registration number: NCT05231109, Date of registration:27/01/2022 (Retrospectively registered).